研究进展

用视觉 Transformer 画全生命周期功能连接的轨迹

来源:Int J Neural Syst · PMID 42935467 · DOI 10.1142/S0129065727500304** · 来源:IMA 知识库《文献层·文献监控卡片》2026-10-29 期 · 摘要级(file_id dGBunAeRiRlm,下载实测 692,872 B) · 摘要级,未获取付费墙全文

数据日期 2026-10-29 · 生成时间 2026-10-29 06:03

证据级别:摘要级。本条依据 PubMed 结构化摘要与元数据撰写,付费墙全文未获取、未逐节核验,本站未做任何数值推算补全。

研究问题

Brain aging involves widespread reorganization of functional networks, yet characterizing these changes across the lifespan remains challenging.

方法

This study presents an innovative application of a Vision Transformer (ViT) to resting-state fMRI (rs-fMRI) functional connectivity for age group classification using the Human Connectome Project (HCP) Lifespan datasets.

核心结论

A ViT model was fine-tuned on [Formula: see text] ROI-to-ROI connectivity matrices to perform three binary age group classifications (Young versus Old, Adult versus Aging, Young versus Aging).;The model achieved accuracies of 91%, 71%, and 93%, respectively, under five-fold cross-validation.;To interpret model decisions, attention weight maps from the final transformer encoder layer were extracted using attention rollout and thresholded with a scree plot analysis, identifying 48 high-salience connections across 28 brain regions.;These features were analyzed across the lifespan using generalized additive models (GAM), and k-means clustering of the trajectories revealed three dominant lifespan connectivity patterns: Age-Declining, Mid-Life Peaking, and Age-Increasing. ‖ 结论:This study demonstrates the viability of the ViT for functional connectome analysis and shows that attention-based interpretability combined with GAM trajectory analysis can enrich insights into age-related changes in brain network connectivity, offering a framework for interpretable brain-age modeling.

局限

未能获取全文,具体设计细节、失访与统计学处理无法核验。

对本项目的价值

★★☆☆☆ 脑老化是最大未满足需求,也是终点最难量化的领域;biomarker 与认知读数选择最敏感。

原文题录

  • 英文标题:Mapping Lifespan Functional Connectivity with Vision Transformer and Attention-Guided Trajectory Analysis.
  • 期刊与标识:Int J Neural Syst · PMID 42935467 · DOI 10.1142/S0129065727500304**

A 级证据分级:A 级(同行评议人体研究)

本文属人体研究证据,但需注意:观察性或小样本干预的结论不等于已证实临床获益;效应量与长期安全性仍需更大规模、更长随访的试验验证。

关于本文的文献来源:本站依据 IMA 知识库「五刊监控·深度文献卡片」(SOP §4.2 摘要级)撰写,依据期刊公开摘要与 PubMed 元数据;付费墙全文未获取之处已标注「待补全文」,未做任何数值推算补全。